Anti-human Amphiregulin Antikörper mit vom Kollaborateur getestetem Nachweis für IF/ICC.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human Amphiregulin Antibody is a research-use antibody from Elabscience for studying Amphiregulin in IF/ICC workflows with listed reactivity for Human. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP |
|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
Amphiregulin (AREG) is an epidermal growth factor family ligand produced as a membrane precursor and released as a soluble growth factor. This catalogue-backed ABMIUM record links human AREG (NCBI Gene 374; UniProt P15514) to research reagents for EGFR-ligand biology.
Biological function: Amphiregulin (AREG) binds and activates the epidermal growth factor receptor (EGFR), triggering receptor-tyrosine-kinase signalling that supports epithelial-cell proliferation, survival and tissue growth. It functions in autocrine and paracrine signalling and is produced initially as a transmembrane precursor.
